
|Videos|October 22, 2013
Regulation of Compounding Pharmacies
David G. Miller, RPh, discusses whether and how regulation of compounding pharmacies needs to change.
Advertisement
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5





































































































































































































